Credit Suisse’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $830M | Sell |
6,287,644
-227,868
| -3% | -$28.1M | 0.79% | 18 |
|
|
2023
Q4 | $710M | Sell |
6,515,512
-805,938
| -11% | -$83.7M | 0.68% | 20 |
|
|
2023
Q3 | $754M | Buy |
7,321,450
+168,675
| +2% | +$18.2M | 0.77% | 18 |
|
|
2023
Q2 | $825M | Sell |
7,152,775
-463,607
| -6% | -$52.6M | 0.82% | 15 |
|
|
2023
Q1 | $810M | Sell |
7,616,382
-73,619
| -1% | -$7.95M | 0.82% | 15 |
|
|
2022
Q4 | $853M | Sell |
7,690,001
-100,528
| -1% | -$10.3M | 0.91% | 12 |
|
|
2022
Q3 | $671M | Sell |
7,790,529
-201,743
| -3% | -$18M | 0.75% | 16 |
|
|
2022
Q2 | $729M | Buy |
7,992,272
+749,609
| +10% | +$66.5M | 0.76% | 16 |
|
|
2022
Q1 | $594M | Sell |
7,242,663
-702,675
| -9% | -$55.4M | 0.51% | 23 |
|
|
2021
Q4 | $609M | Buy |
7,945,338
+589,040
| +8% | +$46.9M | 0.32% | 47 |
|
|
2021
Q3 | $553M | Buy |
7,356,298
+26,997
| +0.4% | +$2.05M | 0.3% | 49 |
|
|
2021
Q2 | $566M | Sell |
7,329,301
-149,630
| -2% | -$11.1M | 0.3% | 47 |
|
|
2021
Q1 | $550M | Sell |
7,478,931
-115,857
| -2% | -$8.55M | 0.28% | 57 |
|
|
2020
Q4 | $593M | Buy |
7,594,788
+71,349
| +0.9% | +$5.46M | 0.29% | 60 |
|
|
2020
Q3 | $595M | Buy |
7,523,439
+393,982
| +6% | +$30.9M | 0.36% | 40 |
|
|
2020
Q2 | $526M | Buy |
7,129,457
+376,652
| +6% | +$28.4M | 0.38% | 43 |
|
|
2020
Q1 | $496M | Sell |
6,752,805
-1,214,358
| -15% | -$95.4M | 0.43% | 35 |
|
|
2019
Q4 | $691M | Buy |
7,967,163
+1,663,282
| +26% | +$137M | 0.5% | 26 |
|
|
2019
Q3 | $506M | Buy |
6,303,881
+603,583
| +11% | +$48.4M | 0.43% | 34 |
|
|
2019
Q2 | $456M | Buy |
5,700,298
+451,228
| +9% | +$34.6M | 0.4% | 35 |
|
|
2019
Q1 | $417M | Sell |
5,249,070
-814,356
| -13% | -$60.9M | 0.38% | 35 |
|
|
2018
Q4 | $442M | Sell |
6,063,426
-135,764
| -2% | -$9.58M | 0.46% | 35 |
|
|
2018
Q3 | $420M | Buy |
6,199,190
+241,921
| +4% | +$15.4M | 0.38% | 35 |
|
|
2018
Q2 | $345M | Sell |
5,957,269
-1,216,380
| -17% | -$68.6M | 0.34% | 37 |
|
|
2018
Q1 | $373M | Sell |
7,173,649
-2,709,795
| -27% | -$146M | 0.35% | 42 |
|
|
2017
Q4 | $531M | Buy |
9,883,444
+4,228,679
| +75% | +$234M | 0.47% | 31 |
|
|
2017
Q3 | $345M | Sell |
5,654,765
-160,736
| -3% | -$9.74M | 0.34% | 46 |
|
|
2017
Q2 | $356M | Sell |
5,815,501
-1,735,687
| -23% | -$106M | 0.35% | 48 |
|
|
2017
Q1 | $458M | Buy |
7,551,188
+1,610,672
| +27% | +$97.7M | 0.41% | 37 |
|
|
2016
Q4 | $334M | Sell |
5,940,516
-2,567,643
| -30% | -$150M | 0.33% | 52 |
|
|
2016
Q3 | $507M | Buy |
8,508,159
+2,829,221
| +50% | +$165M | 0.48% | 29 |
|
|
2016
Q2 | $312M | Sell |
5,678,938
-252,383
| -4% | -$13.4M | 0.35% | 45 |
|
|
2016
Q1 | $299M | Sell |
5,931,321
-1,013,545
| -15% | -$49.6M | 0.36% | 48 |
|
|
2015
Q4 | $350M | Buy |
6,944,866
+231,659
| +3% | +$11.7M | 0.4% | 38 |
|
|
2015
Q3 | $316M | Sell |
6,713,207
-406,389
| -6% | -$21.6M | 0.38% | 43 |
|
|
2015
Q2 | $387M | Buy |
7,119,596
+251,869
| +4% | +$14.1M | 0.38% | 40 |
|
|
2015
Q1 | $377M | Sell |
6,867,727
-1,367,840
| -17% | -$77.5M | 0.38% | 40 |
|
|
2014
Q4 | $446M | Buy |
+8,235,567
| New | +$459M | 0.4% | 38 |
|
|
2014
Q3 | – | Sell |
-7,799,763
| Closed | -$431M | – | 4579 |
|
|
2014
Q2 | $431M | Buy |
7,799,763
+284,477
| +4% | +$15.5M | 0.35% | 38 |
|
|
2014
Q1 | $407M | Sell |
7,515,286
-627,731
| -8% | -$32.5M | 0.4% | 36 |
|
|
2013
Q4 | $389M | Sell |
8,143,017
-114,615
| -1% | -$5.24M | 0.35% | 39 |
|
|
2013
Q3 | $375M | Sell |
8,257,632
-658,424
| -7% | -$30.1M | 0.37% | 36 |
|
|
2013
Q2 | $395M | Buy |
+8,916,056
| New | +$398M | 0.4% | 32 |
|
Other funds holding MRK
Credit Suisse's MRK Position: Q1 2024 in Review
Credit Suisse reduced its Merck (MRK) stake by 3.5% in Q1 2024, selling an estimated $28.1M and leaving 6,287,644 shares worth $830M. The position accounts for 0.79% of the portfolio, ranked #18.
Credit Suisse first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $853M in Q4 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Credit Suisse held 6,287,644 shares of Merck worth $830M as of Q1 2024.
- Credit Suisse sold 227,868 Merck shares in Q1 2024, an estimated $28.1M.
- Merck made up 0.79% of Credit Suisse's portfolio in Q1 2024, its #18 holding.
- Credit Suisse first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- Credit Suisse's Merck position peaked at $853M in Q4 2022.
- 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.